skip to main content

CORRELATION BETWEEN NEUTROPHIL-LYMPHOCYTE RATIO AND LIPID PROFILE IN TYPE-2 DIABETES MELLITUS

Nadwa Izza Azuma Arifin  -  Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia, Indonesia
Banundari Rachmawati orcid scopus  -  Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia, Indonesia
Meita Hendrianingtyas orcid  -  Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia, Indonesia
*Dwi Retnoningrum orcid scopus  -  Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia

Citation Format:
Abstract

Background: Type 2 diabetes mellitus (T2DM) is a metabolic disease that can cause low-grade chronic inflammation related to insulin resistance. Recently, neutrophil to lymphocyte has become a potential marker of chronic inflammation. An abnormal lipid profile occurs due to lipotoxicity from insulin resistance. Objective: To prove the correlation between NLR and lipid profiles in T2DM patients. Methods: An analytic observational study used a cross-sectional approach to 45 medical records of T2DM patients who received treatment at Nasional Diponegoro Hospital Semarang. This study was conducted from October to November 2022. Data was collected by using consecutive sampling. Analysis of the correlation between NLR and lipid profiles used spearman’s correlation test. Results: The correlation between NLR and HDL cholesterol levels was p=0.035, r=-0.315. The correlation between NLR and cholesterol, LDL cholesterol, and triglyceride levels was p = 0.061, r = -0.281; p = 0.170, r = -0.208; p = 0.563, r = -0.089, respectively. Conclusion: There was a weak negative correlation between NLR and HDL cholesterol levels in T2DM patients, but there was no correlation between NLR and other lipid profiles. 

Fulltext View|Download
Keywords: NLR, cholesterol, HDL, LDL, triglyceride

Article Metrics:

  1. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Boyko EJ, Magliano DJ, Karuranga S, Piemonte L, Riley P, Saeedi P, et al., editors. 2021
  2. Jamerson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s Principles of Internal Medicines. 20th ed. USA: McGraw-Hill Education; 2018. 2850–2909 p
  3. Wan H, Wang Y, Fang S, Chen Y, Zhang W, Xia F, et al. Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study. J Diabetes Res. 2020:1–9
  4. Sun HJ, Wu ZY, Nie XW, Bian JS. Role of endothelial dysfunction in cardiovascular diseases: The link between inflammation and hydrogen sulfide. Front Pharmacol. 2020;10(1568):1–15
  5. Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int J Mol Sci. 2022;23(7):1–10
  6. Firooz M, Moradi B, Hosseini SJ. Leukocytosis in Diabetic Ketoacidosis; Whether the Time Has Come to Start Antibiotics? A Short Literature Review. Patient Saf Qual Improv J. 2019;7(1):27–8
  7. Bajpai A, Tilley DG. The Role of Leukocytes in Diabetic Cardiomyopathy. Front Physiol. 2018;9(1547):1–12
  8. Wibisana KA, Subekti I, Antono D, Nugroho P. Hubungan antara Rasio Neutrofil Limfosit dengan Kejadian Penyakit Arteri Perifer Ekstremitas Bawah pada Penyandang Diabetes Melitus Tipe 2. J Penyakit Dalam Indones. 2019;5(4):184–8
  9. Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb. 2018;25(9):771–82
  10. Ma M, Liu H, Yu J, He S, Li P, Ma C, et al. Triglyceride is independently correlated with insulin resistance and islet beta cell function: A study in population with different glucose and lipid metabolism states. Lipids Health Dis. 2020;19(121):1–12
  11. Eftekharian MM, Karimi J, Safe M, Sadeghian A, Borzooei S, Siahpoushi E. Investigation of the correlation between some immune system and biochemical indicators in patients with type 2 diabetes. Hum Antibodies. 2016;24(1–2):25–31
  12. Aboulmakarim S, Boukhira A, Sayagh S, Chellak S. Association of Lipid Ratios and Neutrophil-lymphocyte Ratio in Type 2 Diabetic Moroccan Patients Without Chronic Kidney Disease. Am J Lab Med. 2021;6(6):107–13
  13. Dudani S, Poodury S, Mangalesh S. Study of neutrophil-lymphocyte ratio (NLR) in recent onset type 2 diabetes mellitus. Bali Med J. 2021;10(1):11–6
  14. Syauqy A, Hsu CY, Rau HH, Chao JCJ. Association of dietary patterns, anthropometric measurements, and metabolic parameters with C-reactive protein and neutrophil-to-lymphocyte ratio in middle-aged and older adults with metabolic syndrome in Taiwan: A cross-sectional study 11 Medical and Hea. Nutr J. 2018;17(1):1–12
  15. Mete B, Sait Değer M, Zoroğlu G. Relationship between blood lipids, inflammation parameters and body composition. Cukurova Med J Cukurova Med J. 2020;45(4):1555–61
  16. Quan K, Wang A, Zhang X, Meng X, Chen P, Li H, et al. Neutrophil to lymphocyte ratio and adverse clinical outcomes in patients with ischemic stroke. Ann Transl Med. 2021;9(13):1047–1047
  17. Weir CJ, Sattar N, Walters MR, Lees KR. Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis. 2003;16(1):76–82
  18. Walzik D, Joisten N, Zacher J, Zimmer P. Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index. Eur J Appl Physiol. 2021;121(7):1803–14
  19. Solymár M, Ivic I, Pótó L, Hegyi P, Garami A, Hartmann P, et al. Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly – A meta-analysis. PLoS One. 2018;13(11):e0207947
  20. Saisho Y. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. Endocrine, Metab Immune Disord Targets. 2015;15:196–205
  21. Omodanisi EI, Tomose Y, Okeleye BI, Ntwampe SKO, Aboua YG. Prevalence of dyslipidaemia among type 2 diabetes mellitus patients in the Western Cape, South Africa. Int J Environ Res Public Health. 2020;17(23):1–12
  22. Kemba M, Suguna S. Neutrophil-Lymphocyte Ratio: A Risk Predictor in Patients with Type 2 Diabetes Mellitus. Int J Physiol. 2017;5(1):166–70
  23. Feingold KR, Grunfeld C. Effect of inflammation on HDL structure and function. Curr Opin Lipidol. 2016;27(5):521–30
  24. Farbstein D, Levy AP. HDL dysfunction in diabetes: Causes and possible treatments. Expert Rev Cardiovasc Ther. 2012;10(3):353–61
  25. Gordon SM, Amar MJ, Jeiran K, Stagliano M, Staller E, Playford MP, et al. Effect of niacin monotherapy on high density lipoprotein composition and function. Lipids Health Dis. 2020;19(1):1–10
  26. Wu Z, Huang Z, Lichtenstein AH, Liu Y, Chen S, Jin Y, et al. The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL. BMC Med. 2021;19(1):1–11
  27. Pinakesty A, Azizah RN. Correlation Between Lipid Profile with Type 2 Diabetes Mellitus Progression. JIMKI. 2020;8(2):66–72
  28. Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia: Implications for atherogenesis and treatment. Clin Lipidol. 2011;6(4):401–11
  29. Linton MF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL, et al. The Role of Lipids and Lipoproteins in Atherosclerosis. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2019 [cited 2022 Dec 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK343489/
  30. Jin X, Yang S, Lu J, Wu M. Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies. Front Cardiovasc Med. 2022;8(2):1–14
  31. Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15(1):5841–6
  32. Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, Israeli E, et al. Changes in Triglyceride Levels Over Time and Risk of Type 2 Diabetes in Young Men. Diabetes Care. 2008;31(10):2032
  33. Ren Y, Ren Q, Lu J, Guo X, Huo X, Ji L, et al. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China. Diabetes Metab Res Rev. 2018;34(2)

Last update:

No citation recorded.

Last update:

No citation recorded.